Driving Forces Behind the Growth of the Regional Penicillin Market

The burgeoning demand for penicillin in this region is attributed to the rising incidence of infectious diseases such as pneumonia in this region. For instance, according to the national foundation of infectious disease 2022, report, pneumococcal pneumonia causes at least 150,000 hospitalizations each year. Additionally, the rising incidence of pressure injury of skin and soft tissue amongst the geriatric population is also driving the demand for the penicillin market. For instance, according to Agency for Healthcare Research and Quality, each year more than 2.5 million people in the United States develop pressure injury. This is propelling the demand for antibiotics for treating infected pressure ulcers. Further, the company’s focus towards research and development for the development of novel antibiotics along with the antibiotic’s FDA approvals is also propelling the market growth in this region. For instance, in May 2023, US FDA approved Xacduro consisting of (sulbactam for injection; durlobactam for injection) this is structurally similar to penicillin and is used in the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). Furthermore, the presence of key players in this region is also anticipated to boost the market growth of penicillin in this region. Thus, all the above-mentioned factors are anticipated to boost the market growth for the penicillin market in this region.

Access sample report (including graphs, charts, and figures): https://univdatos.com/report/penicillin-market/get-a-free-sample-form.php?product_id=41214

North America Penicillin Market Revenue (2020-2028) – USD Mn

For a detailed analysis of the Global Penicillin Market browse through – https://univdatos.com/report/penicillin-market/

Based on type, the market is segmented into amino penicillin, beta-lactamase inhibitors, natural penicillin, and penicillinase resistance penicillin. Amongst these, the beta-lactamase inhibitors are anticipated to grow with a significant CAGR in the forecasted period. This is attributed towards the growing resistance to beta-lactam antibiotics.
Based on the route of administration, the market is segmented into oral, intravenous, and intramuscular. Amongst these, the oral route of administration is growing with a significant CAGR. This is attributed to the patient convenience and compliance factor
Based on the end-user, the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Penicillin is a commonly prescribed antibiotic for a wide range of infections.
Global Penicillin Market Segmentation

Market Insight, by Type

• Amino penicillin
• Beta-lactamase Inhibitors
• Natural Penicillin
• Penicillinase Resistance Penicillin

Market Insight, by Route of Administration

• Oral
• Intramuscular
• Intravenous

Market Insights, by End-Users

• Hospitals
• Clinics
• Research Institutes

Market Insight, by Region

North America
U.S.
Canada
Rest of North America
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
APAC
China
Japan
India
South Korea
Rest of APAC
Rest of the World

Top Company Profiles

Pfizer Inc.
Lupin. 
Bayer AG
Novartis Pharmaceuticals Corporation
GSK plc.
Merck & Co., Inc.,
Astellas Pharma Inc.
Sanofi
Gilead Sciences, Inc. 
FUJIFILM Toyama Chemical Co., Ltd.